This PDL reference tool is to aid a prescribing physician with generic availability and preferred product status. A “substitution allowed” physician signature on a prescription should not require a PA to be obtained if a generic agent is available.
glyburide and metformin
glipizide and metformin
Actoplus Met Duetact Glucovance* Janumet Metaglip* Prandimet**
*Denotes a generic available in at least one dosage form or strength **Will be reviewed at a future time when eligible